[Research Articles] Elevated plasma {beta}-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy

This study demonstrates that elevated plasma β-OHB predicts MACE in probands and disease progression in patients with AC and their clinically asymptomatic relatives.

Source: Science Translational Medicine - February 11, 2020 Category: Biomedical Science Authors: Song, J.-P., Chen, L., Chen, X., Ren, J., Zhang, N.-N., Tirasawasdichai, T., Hu, Z.-L., Hua, W., Hu, Y.-R., Tang, H.-R., Chen, H.-S. V., Hu, S.-S. Tags: Research Articles Source Type: research